COMPARISON OF ORIGINAL AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE AND MULTICENTRIC STUDY INĀ  SPAIN

Conference
25th UEG Week 2017


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing